Articles From: Blue Nile Adds Augmented Reality to Popular "Dream Box" Feature in New Mobile App to BlueLinx Announces Third-Quarter Results


SEATTLE, Oct.
Sign-up for Blue Nile Adds Sloane Street and Lisa Jenks to Designer Collective investment picks
Third Quarter Net Sales Increased 6.9% to $105.8 million Third Quarter International Net Sales Increased 25.6% to $21.5 million Third Quarter Earnings Per Diluted Share Total $0.14 Year-To-Date, the Company Repurchased 1.2 million Shares SEATTLE, Oct.
Sign-up for Blue Nile Announces Third Quarter 2014 Financial Results investment picks
2014/10/29
Homeowners search for unique ways to set tone for entire year ahead; find inspiration in possible harmony, creative, worldly and quality possibilities PITTSBURGH , Oct.
Sign-up for Blue Paisley Named 2015 Color of the Year by PPG PITTSBURGH PAINTS' THE VOICE OF COLOR Program investment picks
2014/10/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974158001&sourceType=1 http://media3.marketwire.com/docs/33331.jpg TORONTO, ONTARIO --
Sign-up for Blue Ribbon Income Fund Declares Distributions investment picks
2014/11/28
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981443001&sourceType=1 http://media3.marketwire.com/docs/33331.jpg TORONTO, ONTARIO --
Sign-up for Blue Ribbon Income Fund Renews Normal Course Issuer Bid investment picks
CANTON, Ga., Sept.
Sign-up for Blue Water Finalizes Second Significant Equity Investment investment picks
CANTON, Ga., Dec.
Sign-up for Blue Water Prepares for Rum Distribution, Secures Warehouse investment picks
CANTON, Ga., Oct.
Sign-up for Blue Water Provides General Shareholder Update investment picks
CANTON, Ga., Nov.
Sign-up for Blue Water Reduces Outstanding Common Shares by 54.3% investment picks
bluebird bio, Inc. (Nasdaq: BLUE) today announced data from eight subjects treated with LentiGlobin BB305 drug product.
Sign-up for bluebird bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-Free investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that the first subject with severe sickle cell disease has undergone infusion with bluebird bio’s LentiGlobin BB305 drug product in an autologous hematopoietic stem cell transplantation.
Sign-up for bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene Therapy investment picks
bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended September 30, 2014.
Sign-up for bluebird bio Reports Fiscal Third Quarter 2014 Financial Results investment picks
bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Credit Suisse First Boston Bank Health Care Conference on Thursday, November 13, 2014 at 8:00 AM (MST) at the Biltmore Hotel, Phoenix, Arizona.
Sign-up for bluebird bio to Present at Three Upcoming Health Care Conferences investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that data from its ongoing Phase 1/2 HGB-205 and Northstar Studies of LentiGlobin BB305 Drug Product will be presented at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place December 6 – 9, 2014 in San Francisco, California.
Sign-up for bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference investment picks
By Ron Winslow SAN FRANCISCO--Four patients with a lethal blood disorder were able to forgo life-sustaining blood transfusions within 90 days after they were treated with a technique to replace the defective gene responsible for their disease, researchers said Monday.
Sign-up for Bluebird gene therapy shows promise for lethal blood disease investment picks
2014/12/9
Cracker Barrel Old Country Store® and three-time GRAMMY Award winner and International Bluegrass Hall of Honor inductee Dr.
Sign-up for Bluegrass Legend Dr. Ralph Stanley and Cracker Barrel Old Country Store® Announce Exclusive CD, Ralph Stanley & Friends: Man of Constant Sorrow, Available Jan. 19, 2015 investment picks
Quickly and Easily Build and Scale New or Existing Blogs In the Cloud OREM, Utah , Oct.
Sign-up for Bluehost Launches Optimized Hosting for WordPress investment picks
Blueknight Energy Partners, L.P. (NASDAQ: BKEP)(NASDAQ: BKEPP) ("BKEP" or the "Partnership"), a midstream energy company focused on providing integrated services for companies engaged in the production, distribution and marketing of crude oil, asphalt and other petroleum products, announced today that the board of directors of its general partner has declared quarterly cash distributions of $0.1345 per common unit, a 1.5% increase over the previous quarter's distribution and a 9.8% increase over the third quarter of 2013's distribution, and $0.17875 per preferred unit payable on November 14, 2014 on all outstanding common and preferred units to unitholders of record as of the close of business on November 4, 2014.
Sign-up for Blueknight Declares Quarterly Distributions investment picks
Blueknight Energy Partners, L.P. (NASDAQ: BKEP) (“BKEP” or the “Partnership”) today announced the commencement of an underwritten public offering of 8,500,000 common units representing limited partner interests of the Partnership.
Sign-up for Blueknight Energy Partners Announces Public Offering of Common Units investment picks
Blueknight Energy Partners, L.P. (NASDAQ: BKEP) (“BKEP” or the “Partnership”) today announced that it has priced an underwritten public offering of 8,500,000 common units representing limited partner interests of the Partnership at a public offering price of $7.61 per common unit.
Sign-up for Blueknight Energy Partners Prices Public Offering of Common Units investment picks
Blueknight Energy Partners, L.P. (“BKEP” or the “Partnership”) (NASDAQ: BKEP) (NASDAQ: BKEPP), a midstream energy company focused on providing integrated services for companies engaged in the production, distribution and marketing of crude oil, asphalt and other petroleum products, today announced adjusted EBITDA of $20.2 million for the third quarter of 2014 as compared to $26.0 million for the same period in 2013.
Sign-up for Blueknight Energy Partners, L.P. Announces Third Quarter 2014 Results investment picks
Blueknight Energy Partners, L.P. ("BKEP" or the "Partnership") (NASDAQ: BKEP) (NASDAQ: BKEPP), a midstream energy company focused on providing integrated services for companies engaged in the production, distribution and marketing of crude oil, asphalt and other petroleum products, plans to release third quarter 2014 results after the market closes on Wednesday, November 5, 2014.
Sign-up for Blueknight Energy Partners, L.P. Announces Timing of Third Quarter 2014 Financial Results and Conference Call investment picks
Mark Hurley, Chief Executive Officer; Brian Melton, Vice-President of Business Development; and Alex Stallings, Chief Financial Officer of Blueknight Energy Partners, L.P. (“BKEP” or the “Partnership”) (NASDAQ: BKEP) (NASDAQ: BKEPP), a midstream energy company focused on providing integrated services for companies engaged in the production, distribution and marketing of crude oil, asphalt and other petroleum products, will participate in the 2014 Wells Fargo Energy Symposium on December 9 and 10 in New York City.
Sign-up for Blueknight Energy Partners, L.P. To Participate in the 2014 Wells Fargo Energy Symposium investment picks
- Adjusted EBITDA of $11.1 Million Best Since 2008 - - Excess Availability of $88 million - ATLANTA, Nov.
Sign-up for BlueLinx Announces Third-Quarter Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Blue Nile Adds Augmented Reality to Popular "Dream Box" Feature in New Mobile App to BlueLinx Announces Third-Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent